Efficacy of lidocaine versus mepivacaine in the management of myofascial pain

Albagieh, Hamad; Aloyouny, Ashwag; Alshehri, Nojoud; Alsammahi, Noor; Almutrafi, Dima; Hadlaq, Emad M

doi:10.1016/j.jsps.2020.08.014

Cited by 3 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regardless of which of these agents the patient was given, they reported a significant reduction in pain following injection with local anesthetics. Mepivacaine showed a stronger pain reduction immediately after injection, however, in the long term, both substances show a similar effect [20].…”

Section: Injections With Local Anestheticsmentioning

confidence: 89%

“…There is much controversy regarding trigger point therapy. Despite the existence of multiple techniques acting on trigger points for the treatment of pain [20][21][22][23], there are many opposing views on this topic. There are papers showcasing the serious side effects that come as a result of pain treatment on trigger points, suggesting the occurrence of ischemic stroke after needle therapy [36,37].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Trigger points in medical practice - current therapeutic directions

Wanat¹,

Nowak²,

Świątko³

et al. 2022

Medical Journal of Cell Biology

View full text Add to dashboard Cite

Recent scientific evidence suggests that one of the causes of myofascial pain syndromes responsible for the occurrence of chronic headaches, among other things, may be increased or impaired with trigger point therapy. This paper presents the results of a non-systematic literature review on trigger point therapy. The analysis shows a clear increase in scientific interest in invasive trigger point pain treatment techniques. Invasive therapy consists primarily of the use of injections and dry needling. Injections of anesthetics or botulinum toxin are methods that, in addition to their possible therapeutic effect, may carry side effects. In contrast, dry needling does not have a fully scientifically-proven effect. Recent scientific data also indicates that the aforementioned method may have a limited clinical effect. The performed analysis did not demonstrate a significant advantage in invasive techniques over typical non-invasive techniques. It is therefore necessary to design randomized multi-center clinical trials to definitively verify the efficacy of these techniques in the treatment of tension-type trigger point-dependent myofascial pain.

show abstract

Section: Injections With Local Anestheticsmentioning

confidence: 89%

Section: Discussionmentioning

confidence: 99%

Trigger points in medical practice - current therapeutic directions

Wanat¹,

Nowak²,

Świątko³

et al. 2022

Medical Journal of Cell Biology

View full text Add to dashboard Cite

show abstract

Comparison of kinesio taping, dry needling and lidocaine injection methods in myofascial pain syndrome

Kara,

Solum,

Saglam

et al. 2024

Journal of Bodywork and Movement Therapies

View full text Add to dashboard Cite

Efficiency of Lidocaine Intramuscular and Intraosseous Trigger Point Injections in the Treatment of Residual Chronic Pain after Degenerative Lumbar Spinal Stenosis Decompression Surgery

Al-Zamil,

Kulikova,

Shnayder

et al. 2024

JCM

View full text Add to dashboard Cite

Introduction: Despite the long-term use of intramuscular and intraosseous lidocaine trigger point injections (LTPI) in the treatment of patients with low back pain, there have been no studies examining their efficiency in treatment of residual pain after degenerative lumbar spinal stenosis (DLSS) decompression surgery. The purpose of our research is to examine the LTPI efficiency in the treatment of residual lumbar pain after DLSS decompression surgery and to compare the analgesic and recovery effects of intramuscular and intraosseous LTPI administered in the L4–S1 region and in the posterior superior iliac spine (PSIS) after treatment and during four months of follow-up. Materials and Methods: We observed 99 patients (F:50, M:49) aged 42 to 59 years with residual neurological disorders after DLSS decompression surgery. In all patients, the pain syndrome exceeded 6 points on the VAS and averaged 7.2 ± 0.11 points. The control group (n = 21) underwent only pharmacotherapy. In addition to pharmacotherapy, the LTPI group underwent intramuscular LTPI in L4–S1 (n = 20), intramuscular LTPI in the PSIS (n = 19), intraosseous LTPI in L5, S1 (n = 20), and intraosseous LTPI in the PSIS (n = 19). A neurological examination was carried out before treatment, 7 days after completion of treatment, and at the end of the second and fourth months of the follow-up period. Results: In the control group, intramuscular LTPI in L4–S1 subgroup, intramuscular LTPI in PSIS subgroup, intraosseous LTPI in L5, S1 subgroup, and intraosseous LTPI in PSIS subgroup, the severity of pain decreased after treatment by 27.1% (p ≤ 0.05), 41.7% (p ≤ 0.01), 50.7% (p ≤ 0.01), 69% (p ≤ 0.01), and 84.7% (p ≤ 0.01), respectively, and at the end of the second month of follow-up, by 14.3% (p > 1), 29.2% (p ≤ 0.05), 38% (p ≤ 0.01), 53.5% (p ≤ 0.01), and 72.2% (p ≤ 0.01), respectively. Reduction of neurogenic claudication, regression of sensory deficit, increase of daily step activity, and improvement of quality of life after treatment were noted in intramuscular LTPI subgroups by 19.6% (p ≤ 0.05), 36.4 (p ≤ 0.05), 40.3% (p ≤ 0.01), and 21.0% (p ≤ 0.05), respectively, and in interosseous LTPI subgroups by 48.6% (p ≤ 0.01), 67.4% (p ≤ 0.01), 68.3% (p ≤ 0.01), and 46% (p ≤ 0.01), respectively. Conclusions: LTPI is highly effective in the treatment of patients with residual pain after DLSS decompression surgery. High analgesic effect, significant regression of sensory deficits and gait disorders, and remarkable improvement of daily step activity and quality of life are noted not only after the end of LTPI treatment but also continue for at least 2 months after treatment. Intraosseous LTPI is more effective than intramuscular LTPI by 92%, and LTPI in PSIS is more effective than LTPI in L4–S1 by 28.6%.

show abstract

Efficacy of lidocaine versus mepivacaine in the management of myofascial pain

Cited by 3 publications

References 27 publications

Trigger points in medical practice - current therapeutic directions

Trigger points in medical practice - current therapeutic directions

Comparison of kinesio taping, dry needling and lidocaine injection methods in myofascial pain syndrome

Efficiency of Lidocaine Intramuscular and Intraosseous Trigger Point Injections in the Treatment of Residual Chronic Pain after Degenerative Lumbar Spinal Stenosis Decompression Surgery

Contact Info

Product

Resources

About